J&J psoriasis drug posts mixed results in trial
306
Johnson & Johnson  said on  Wednesday its new type of treatment for psoriasis was highly  effective in a mid-stage trial, but was linked to an increased  risk of serious adverse events, including heart attacks.
149032
The stock is feeling some pain these days. However, this drugmaker has enough going for it that the illness shouldn&#39;t last. Amid nervousness over the future of Pfizer&#39;s arthritis pain treatment Celebrex and
101669
A new analysis finds that clinical trials of breast-cancer treatments by drugmakers show positive results far more often than non-industry trials. Why the difference?
316322
US News, WASHINGTON - Researchers said on Sunday they may have discovered what causes psoriasis, a common and irritating skin ailment, and said their findings may open the way to an effective treatment.
560221
J&J gains pediatric approval of its antipsychosic drug.
528016
Pfizer Inc. on Friday said two clinical trials showed patients taking its anti-inflammatory drug Bextra had a higher risk of cardiovascular events during high-risk coronary bypass surgery.
51892
The withdrawal of Vioxx by competitor Merck has given Pfizer&#39;s two top arthritis drugs a huge share of the world market. But some of the same issues that forced the Vioxx withdrawal still swirl around Pfizer&#39;s Celebrex and Bextra.
25622
The German biotechnology company Paion and its American partner, Forest Laboratories, announced the outcomes of the trial of its drug, desmoteplase.
40489
People who suffer from severe psoriasis die younger than people with mild cases or without the disease, for reasons that are unclear, researchers said on Monday.
253904
NEW YORK  - Psoriasis sufferers have an increased frequency of a variety of cardiovascular risk factors including diabetes, obesity, high blood pressure, elevated blood cholesterol levels, and smoking, results of a study confirm.
161495
Progress on its lead drug remains stalled.
398157
An experimental cholesterol treatment touted by drugmaker Merck &amp; Co. significantly reduced artery-clogging fats in late-stage testing, but it got a mixed reception from Wall Street analysts Tuesday.
319148
A Johnson & Johnson promotion for  rheumatoid arthritis drug Remicade is misleading because it  makes unsupported claims about the drug's effectiveness and  omits important information about risks, U.S. regulators said  in a letter released on Monday.
39561
NEW YORK  - Targretin (bexarotene), a drug  that is used to treat lymphoma of the skin, also appears useful  against the scaly skin condition psoriasis, Dutch researchers  report.
596071
ATLANTIC CITY, New Jersey  - A New Jersey jury found on Friday that Merck & Co.  failed to provide adequate warnings about health risks tied to its withdrawn arthritis drug Vioxx in one case, but decided that it gave adequate warning in another in two suits tried simultaneously.
465932
Researchers said on Sunday they may  have discovered what causes psoriasis, a common and irritating  skin ailment, and said their findings may open the way to an  effective treatment.
332083
Bristol-Myers Squibb Co. said on  Sunday its experimental drug for rheumatoid arthritis showed  highly promising results in two late-stage clinical trials.